| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | $0.1B |
| Gross Profit | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $-0.0B | $-0.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Operating Income | $0.0B | $0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Net Income | $0.0B | $0.0B | $-0.0B | $0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| EPS (Basic) | $0.05 | $0.36 | $-0.48 | $0.15 | $-0.12 | $-0.09 | $-0.79 | $-0.46 |
| EPS (Diluted) | $0.05 | $0.36 | $-0.48 | $0.15 | $-0.12 | $-0.09 | $-0.79 | $-0.46 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Current Assets | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B |
| Stockholders' Equity | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $-0.0B | $0.0B | $-0.0B | — | — | — | — |
| Investing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $0.0B | $-0.0B | $0.0B | $-0.0B | $-0.0B | $0.0B | — |